Hjem › Adenokarcinom i spiserøret › Wisconsin
Kliniske studier for Adenokarcinom i spiserøret i Wisconsin
7 studier for Adenokarcinom i spiserøret søker deltakere på steder i Wisconsin.
Byer i Wisconsin
Offisiell studietekst (engelsk)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- og 39 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- og 49 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Milwaukee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
- University of Wisconsin Carbone Cancer Center, Madison
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT04150640Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- UW Carbone Cancer Center, Madison
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04900818Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- Mayo Clinic Health System-Eau Claire, Eau Claire
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 90 · Alle kjønn · Oppdatert 26. jan. 2026 · NCT03961945Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.